About this data
What it is
Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
Who files it
The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
How current
We collect new notices throughout the day on SEC business days.
Terms
Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
Worth knowing
A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.

All of this comes from public filings.

Form 144 notices per day, last 30 days

0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0
0100200300Oct 17 · All notices: 0Oct 17 · Notices that give a 10b5-1 plan: 0Oct 17Oct 18 · All notices: 0Oct 18 · Notices that give a 10b5-1 plan: 0Oct 19 · All notices: 47Oct 19 · Notices that give a 10b5-1 plan: 29Oct 20 · All notices: 52Oct 20 · Notices that give a 10b5-1 plan: 39Oct 21 · All notices: 46Oct 21 · Notices that give a 10b5-1 plan: 26Oct 21Oct 22 · All notices: 49Oct 22 · Notices that give a 10b5-1 plan: 22Oct 23 · All notices: 62Oct 23 · Notices that give a 10b5-1 plan: 23Oct 24 · All notices: 0Oct 24 · Notices that give a 10b5-1 plan: 0Oct 25 · All notices: 0Oct 25 · Notices that give a 10b5-1 plan: 0Oct 25Oct 26 · All notices: 75Oct 26 · Notices that give a 10b5-1 plan: 28Oct 27 · All notices: 71Oct 27 · Notices that give a 10b5-1 plan: 18Oct 28 · All notices: 54Oct 28 · Notices that give a 10b5-1 plan: 17Oct 29 · All notices: 100Oct 29 · Notices that give a 10b5-1 plan: 31Oct 29Oct 30 · All notices: 97Oct 30 · Notices that give a 10b5-1 plan: 35Oct 31 · All notices: 0Oct 31 · Notices that give a 10b5-1 plan: 0Nov 1 · All notices: 0Nov 1 · Notices that give a 10b5-1 plan: 0Nov 2 · All notices: 272Nov 2 · Notices that give a 10b5-1 plan: 133Nov 2Nov 3 · All notices: 142Nov 3 · Notices that give a 10b5-1 plan: 48Nov 4 · All notices: 190Nov 4 · Notices that give a 10b5-1 plan: 77Nov 5 · All notices: 148Nov 5 · Notices that give a 10b5-1 plan: 53Nov 6 · All notices: 127Nov 6 · Notices that give a 10b5-1 plan: 41Nov 6Nov 7 · All notices: 0Nov 7 · Notices that give a 10b5-1 plan: 0Nov 8 · All notices: 0Nov 8 · Notices that give a 10b5-1 plan: 0Nov 9 · All notices: 217Nov 9 · Notices that give a 10b5-1 plan: 75Nov 10 · All notices: 202Nov 10 · Notices that give a 10b5-1 plan: 59Nov 10Nov 11 · All notices: 0Nov 11 · Notices that give a 10b5-1 plan: 0Nov 12 · All notices: 240Nov 12 · Notices that give a 10b5-1 plan: 77Nov 13 · All notices: 127Nov 13 · Notices that give a 10b5-1 plan: 28Nov 14 · All notices: 0Nov 14 · Notices that give a 10b5-1 plan: 0Nov 14Nov 15 · All notices: 0Nov 15 · Notices that give a 10b5-1 plan: 0

All notices Notices that give a 10b5-1 plan

By the day each notice was filed. A notice is a plan to sell, not a sale.

Latest notices of planned insider sales

Reset

Showing: ticker TAK

Latest notices of planned insider sales
FiledInsiderCompanyShares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file.ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for.PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.Expected saleSale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have.Notice
Oct 30, 2026Giles Richard Platford
President, International Business Unit
TAK
Takeda Pharmaceutical Company Limited
55,617$1.1M—Nov 1, 2026Form 4 ↗
6 days later · 55,617 shares
Form 144 ↗
Oct 30, 2026Teresa Bitetti
President, Global Oncology Business Unit
TAK
Takeda Pharmaceutical Company Limited
46,609$940.1K—Nov 1, 2026Form 4 ↗
5 days later · 46,609 shares
Form 144 ↗
Sep 10, 2026Lauren Rusckowski Duprey
Chief Transformation Officer
TAK
Takeda Pharmaceutical Company Limited
34,535$634.4K—Sep 10, 2026Form 4 ↗
5 days later · 34,535 shares
Form 144 ↗
Sep 2, 2026Plump Andrew Stewart
Officer
TAK
Takeda Pharmaceutical Company Limited
116,191$2.1M10b5-1Sep 2, 2026Form 4 ↗
1 day later · 116,191 shares
Form 144 ↗
Aug 19, 2026Plump Andrew Stewart
Officer
TAK
Takeda Pharmaceutical Company Limited
19,651$363.3K10b5-1Aug 19, 2026Form 4 ↗
2 days later · 19,651 shares
Form 144 ↗
Aug 14, 2026Nicola Greenway
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
12,980$225.7K—Aug 14, 2026Form 4 ↗
5 days later · 12,980 shares
Form 144 ↗
Aug 10, 2026Elaine Shannon
President, Global Supply & Quality
TAK
Takeda Pharmaceutical Company Limited
20,363$355.3K—Aug 11, 2026Form 4 ↗
2 days later · 3,978 shares
Form 144 ↗
Aug 6, 2026Nicola Greenway
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
34,603$578.6K—Aug 7, 2026Form 4 ↗
6 days later · 34,603 shares
Form 144 ↗
Jul 13, 2026Marcello Pignagnoli Agosti
Interim Head, Strategy and Portfolio De…
TAK
Takeda Pharmaceutical Company Limited
24,887$416.9K—Jul 13, 2026Form 4 ↗
30 days later · 22,957 shares
Form 144 ↗
Jul 13, 2026Lauren Rusckowski Duprey
Chief Transformation Officer
TAK
Takeda Pharmaceutical Company Limited
51,579$863.9K—Jul 13, 2026Form 4 ↗
30 days later · 47,586 shares
Form 144 ↗
Jul 13, 2026Giles Platford
President, International Business Unit
TAK
Takeda Pharmaceutical Company Limited
33,696$564.4K—Jul 13, 2026Form 4 ↗
30 days later · 31,083 shares
Form 144 ↗
Jul 13, 2026Natalie Furney
Global General Counsel
TAK
Takeda Pharmaceutical Company Limited
33,454$560.4K—Jul 13, 2026Form 4 ↗
30 days later · 30,868 shares
Form 144 ↗
Jul 13, 2026Gabriele Ricci
Chief Data & Technology Officer
TAK
Takeda Pharmaceutical Company Limited
27,197$455.5K—Jul 13, 2026Form 4 ↗
30 days later · 25,088 shares
Form 144 ↗
Jul 13, 2026Nicola Greenway
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
7,348$123.1K—Jul 13, 2026Form 4 ↗
30 days later · 34,603 shares
Form 144 ↗
Jul 13, 2026Elaine Shannon
President, Global Supply & Quality
TAK
Takeda Pharmaceutical Company Limited
4,319$72.4K—Jul 13, 2026Form 4 ↗
30 days later · 3,978 shares
Form 144 ↗
Jul 13, 2026Ramy Riad
President, Plasma-Derived Therapies Bus…
TAK
Takeda Pharmaceutical Company Limited
7,889$132.1K—Jul 13, 2026Form 4 ↗
30 days later · 7,277 shares
Form 144 ↗
Jul 13, 2026Awny Farajallah
Chief Medical Officer
TAK
Takeda Pharmaceutical Company Limited
15,188$254.4K—Jul 13, 2026Form 4 ↗
30 days later · 14,006 shares
Form 144 ↗
Jul 13, 2026Rhonda Pacheco
President, US Business Unit and US Coun…
TAK
Takeda Pharmaceutical Company Limited
18,316$306.8K—Jul 13, 2026Form 4 ↗
30 days later · 16,901 shares
Form 144 ↗
Jul 13, 2026Andrew Plump
President, Research & Development
TAK
Takeda Pharmaceutical Company Limited
179,239$3.0M—Jul 13, 2026Form 4 ↗
30 days later · 165,393 shares
Form 144 ↗
Jul 13, 2026Teresa Bitetti
President, Global Oncology Business Unit
TAK
Takeda Pharmaceutical Company Limited
54,210$908.0K—Jul 13, 2026Form 4 ↗
30 days later · 50,012 shares
Form 144 ↗
Jul 13, 2026Julie Kim
President and CEO
TAK
Takeda Pharmaceutical Company Limited
96,558$1.6M—Jul 13, 2026Form 4 ↗
30 days later · 89,090 shares
Form 144 ↗
Dec 9, 2025Lauren Rusckowski Duprey
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
29,619$421.2K—Dec 9, 2025—Form 144 ↗
Dec 5, 2025Teresa Marie Bitetti
President, Global Oncology Business Unit
TAK
Takeda Pharmaceutical Company Limited
87,023$1.2M—Dec 5, 2025—Form 144 ↗
Dec 4, 2025Giles Richard Platford
President, Plasma-Derived Therapies Bus…
TAK
Takeda Pharmaceutical Company Limited
58,421$836.0K—Dec 4, 2025—Form 144 ↗
Jul 9, 2025Christophe Pierre Weber
Chief Executive Officer
TAK
Takeda Pharmaceutical Company Limited
34,857$537.5K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Akiko Amakawa
Corporate Strategy Officer & CEO Chief…
TAK
Takeda Pharmaceutical Company Limited
5,608$86.5K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Elaine Mary Shannon
Global Quality Officer
TAK
Takeda Pharmaceutical Company Limited
4,477$69.0K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Marcello Pignagnoli Agosti
Global Business Development Officer
TAK
Takeda Pharmaceutical Company Limited
18,622$287.2K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Gabriele Ricci
Chief Data & Technology Officer
TAK
Takeda Pharmaceutical Company Limited
26,874$414.4K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Lauren Rusckowski Duprey
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
40,919$631.0K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Thomas Wozniewski
Global Manufacturing & Supply Officer
TAK
Takeda Pharmaceutical Company Limited
6,136$94.6K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Julie Kim
President, US Business Unit
TAK
Takeda Pharmaceutical Company Limited
58,559$903.0K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Andrew Plump
President, Research & Development
TAK
Takeda Pharmaceutical Company Limited
169,313$2.6M—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Giles Richard Platford
President, Plasma-Derived Therapies Bus…
TAK
Takeda Pharmaceutical Company Limited
28,552$440.3K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Teresa Marie Bitetti
President, Global Oncology Business Unit
TAK
Takeda Pharmaceutical Company Limited
52,649$811.8K—Jul 9, 2025—Form 144 ↗
Jul 9, 2025Ramona A Sequeira
President, Global Portfolio Division
TAK
Takeda Pharmaceutical Company Limited
102,972$1.6M—Jul 9, 2025—Form 144 ↗
Aug 22, 2024Giles Richard Platford
President, Plasma-Derived Therapies Bus…
TAK
Takeda Pharmaceutical Company Limited
19,073$285.0K—Aug 23, 2024—Form 144 ↗
Jul 10, 2024Thomas Wozniewski
Global Manufacturing & Supply Officer
TAK
Takeda Pharmaceutical Company Limited
4,533$59.7K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Teresa Marie Bitetti
President, Global Oncology Business Unit
TAK
Takeda Pharmaceutical Company Limited
38,479$507.2K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Ramona A Sequeira
President, Global Portfolio Division
TAK
Takeda Pharmaceutical Company Limited
74,654$983.9K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Marcello Pignagnoli Agosti
Global Business Development Officer
TAK
Takeda Pharmaceutical Company Limited
10,674$140.7K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Lauren Rusckowski Duprey
Chief Human Resources Officer
TAK
Takeda Pharmaceutical Company Limited
27,603$363.8K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Julie Kim
President, US Business Unit
TAK
Takeda Pharmaceutical Company Limited
37,219$490.5K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Giles Richard Platford
President, Plasma-Derived Therapies Bus…
TAK
Takeda Pharmaceutical Company Limited
20,721$273.1K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Gabriele Ricci
Chief Data & Technology Officer
TAK
Takeda Pharmaceutical Company Limited
6,132$80.8K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Elaine Mary Shannon
Global Quality Officer
TAK
Takeda Pharmaceutical Company Limited
4,612$60.8K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Christophe Pierre Weber
Chief Executive Officer
TAK
Takeda Pharmaceutical Company Limited
14,890$196.3K—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Andrew Plump
President, Research & Development
TAK
Takeda Pharmaceutical Company Limited
121,125$1.6M—Jul 11, 2024—Form 144 ↗
Jul 10, 2024Akiko Amakawa
Corporate Strategy Officer & CEO Chief…
TAK
Takeda Pharmaceutical Company Limited
6,048$79.7K—Jul 11, 2024—Form 144 ↗
Jul 10, 2023Thomas Wozniewski
Global Manufacturing & Supply Officer
TAK
Takeda Pharmaceutical Company Limited
4,789$74.1K—Jul 11, 2023—Form 144 ↗

The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:38 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances